| Oct 18 |
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
|
| Oct 18 |
Boston Scientific stock down as Needham cuts to Hold on growth concerns
|
| Oct 18 |
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
|
| Oct 17 |
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
|
| Oct 17 |
Johnson & Johnson Q3 Earnings Review: Nicely Poised For Steady Growth (Upgrade)
|
| Oct 17 |
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike
|
| Oct 17 |
Does Johnson & Johnson (NYSE:JNJ) Have A Healthy Balance Sheet?
|
| Oct 17 |
Johnson & Johnson price target raised to $181 from $178 at RBC Capital
|
| Oct 17 |
This Magnificent Dividend Stock Is as Healthy as It Gets
|
| Oct 16 |
J&J trims neuroscience pipeline – seltorexant in Alzheimer’s disease dropped
|
